The Agence de la biomédecine is a French national public agency created by the 2004 Bioethics law.
It provides information on and supervises, supports and evaluates healthcare in the areas of
- Organ, tissue and haematopoietic stem cell transplantation
- Assisted Reproductive Technology (ART)
- Prenatal Diagnosis (PND) and Preimplantation Genetic Diagnosis (PGD)
- Human embryo and embryonic stem cell (hESC) research
The General Director of the Agence de la biomédecine is directly supported by a communication department and an inspector department. The general Director has two deputies : one is in charge of the medical and scientific actions and policies, and the other one is in charge of finances, administrative and legal issues and human and material resources.
The agency also provides training for healthcare professionals and a documentation centre.
The Agence de la biomédecine is guided in all its decisions by the management board and an ethical advisory board.
Personnel : 276
Budget : €89 million